Methotrexate — Dosing in CKD & Dialysis

Methotrexate (Antineoplastic): renal dosing adjustments, dialyzability (Neither hemodialysis nor peritoneal dialysis has been shown to improve elimination; effective clearance reported with acute intermittent high-flux hemodialysis), and renal-relevant safety risk for CKD and dialysis patients. Educ

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.